DP VI Associates, L.P., 10% Owner at CADENCE PHARMACEUTICALS INC (CADX), sold 289 shares at $5.01 ($1K) on 2013-02-14, disclosed to the SEC on 2013-02-15.
Scheduled sale ($1k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 191 | $955 | 66.0% |
| 2 | $5.01 | 98 | $491 | 34.0% |
| Total | $5.00 avg | 289 | $1K | 100% |
| Filing → |
| CADX | SELL | 2013-01-28 | $9K | — | Filing → |
| ALIM | SELL | 2011-06-03 | $56K | — | Filing → |
| SOMX | SELL | 2006-12-22 | $87K | — | Filing → |